000			01491 a2200409 4500
005			20250515030723.0
264		0	_c20060801
008			200608s 0 0 eng d
022			_a1556-5653
024	7		_a10.1016/j.fertnstert.2006.04.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aCagnacci, Angelo
245	0	0	_aOral contraceptives and insulin sensitivity. _h[electronic resource]
260			_bFertility and sterility _cJul 2006
300			_ae5; author reply e6 p. _bdigital
500			_aPublication Type: Letter; Comment
650	0	4	_aAdolescent
650	0	4	_aAndrogen Antagonists _xadverse effects
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aCarbohydrate Metabolism _xdrug effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aContraceptives, Oral, Combined _xadverse effects
650	0	4	_aContraceptives, Oral, Synthetic _xadverse effects
650	0	4	_aCyproterone Acetate _xadverse effects
650	0	4	_aDesogestrel _xadverse effects
650	0	4	_aFasting _xblood
650	0	4	_aFemale
650	0	4	_aGlucose Tolerance Test
650	0	4	_aHumans
650	0	4	_aHyperinsulinism _xchemically induced
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin Resistance
650	0	4	_aInsulin Secretion
650	0	4	_aPolycystic Ovary Syndrome _xdrug therapy
773	0		_tFertility and sterility _gvol. 86 _gno. 1 _gp. e5; author reply e6
856	4	0	_uhttps://doi.org/10.1016/j.fertnstert.2006.04.006 _zAvailable from publisher's website
999			_c16346732 _d16346732